Guardant Health - Rising Patient Numbers Provide Strong Prospects for Diagnostics Specialist
Reading Time: 1 minute
Business drivers: Guardant Health (GH) specializes in the development and marketing of blood tests for cancer detection and monitoring. Using so-called "liquid biopsies," the company analyzes circulating tumor DNA in the blood to detect cancer early and treat it individually. With products like "Guardant360" and the colorectal cancer screening test "Shield," Guardant offers a gentle, precise alternative to traditional tissue biopsies. As the number of treatments continues to rise, Guardant Health presents excellent growth prospects in the medium...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
